Correction: HDAC6 inhibition by ITF3756 modulates PD-L1 expression and monocyte phenotype: insights for a promising immune checkpoint blockade co-treatment therapy

  • Front Immunol. 2025 Aug 5:16:1645773. doi: 10.3389/fimmu.2025.1645773.
Valeria Spadotto  #  1 ,  Chiara Ripamonti  #  1 ,  Andrea Ghiroldi  1 ,  Elisabetta Galbiati  2 ,  Pietro Pozzi  2 ,  Roberta Noberini  3 ,  Tiziana Bonaldi  3  4 ,  Christian Steinkühler  1 ,  Gianluca Fossati  1
Affiliations
  • 1. New Drug Incubator Department, Italfarmaco Group, Milan, Italy.
  • 2. Preclinical Drug Development Department, Italfarmaco Group, Milan, Italy.
  • 3. Department of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • 4. Department of Oncology and Hematology-Oncology (DIPO), University of Milan, Milan, Italy.
  • # Contributed equally.
PMID: 40837583 DOI: 10.3389/fimmu.2025.1645773
Abstract

[This corrects the article DOI: 10.3389/fimmu.2025.1546939.].

Keywords
HDAC6; TNF-α; dendritic cells; immuno-checkpoints; monocytes.
Products